文献速递冠心病血脂与心血管预防

急性冠脉综合征有创管理:桡动脉与股动脉入路术后急性肾损伤比较

Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.
PubMed 文献 · J Am Coll Cardiol · 2017-05-11

基于MATRIX-Access试验的8,404例ACS患者,排除194例后分析发现,桡动脉入路组AKI发生率为15.4%,股动脉入路组为17.4%(OR 0.87,95%CI 0.77-0.98,p=0.0181)。桡动脉入路与股动脉入路相比,与急性肾损伤风险降低相关。

要点

  • 桡动脉入路组AKI发生率15.4%,股动脉入路组17.4%,OR 0.87(95%CI 0.77-0.98,p=0.0181)。
  • 血清肌酐相对升高>25%者桡动脉组15.4% vs 股动脉组17.3%(OR 0.87,95%CI 0.77-0.98,p=0.0195)。
  • 血清肌酐绝对升高>0.5 mg/dl者桡动脉组4.3% vs 股动脉组5.4%(OR 0.77,95%CI 0.63-0.95,p=0.0131)。

核心结论

  • 在接受有创管理的ACS患者中,桡动脉入路与股动脉入路相比,与急性肾损伤风险降低相关。

研究设计与样本

  • MATRIX-Access试验的事后分析,纳入8,404例ACS患者,排除194例(2.3%)因肌酐缺失、冠状动脉造影未完成或既往透析者。

主要发现

  • AKI(定义为血清肌酐绝对升高>0.5 mg/dl或相对升高>25%)在桡动脉组634例(15.4%)发生,股动脉组712例(17.4%)发生(OR 0.87,95%CI 0.77-0.98,p=0.0181)。
  • 血清肌酐相对升高>25%者桡动脉组633例(15.4%),股动脉组710例(17.3%)(OR 0.87,95%CI 0.77-0.98,p=0.0195)。
  • 血清肌酐绝对升高>0.5 mg/dl者桡动脉组175例(4.3%),股动脉组223例(5.4%)(OR 0.77,95%CI 0.63-0.95,p=0.0131)。
  • 采用KDIGO标准时AKI患病率降低3倍,桡动脉组有更低趋势(OR 0.85,95%CI 0.70-1.03,p=0.090);3期AKI桡动脉组28例(0.68%)vs 股动脉组46例(1.12%)(p=0.0367)。
  • 干预后需要透析者桡动脉组6例(0.15%),股动脉组14例(0.34%)(p=0.0814)。

关键数值与推荐

  • AKI定义:血清肌酐绝对升高>0.5 mg/dl或相对升高>25%。
  • KDIGO标准下AKI:桡动脉组OR 0.85(95%CI 0.70-1.03,p=0.090),3期AKI桡动脉组0.68% vs 股动脉组1.12%(p=0.0367)。

临床怎么用

  • 在ACS患者有创管理时,桡动脉入路与股动脉入路相比,与急性肾损伤风险降低相关,尤其在高危患者中获益更明显。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI). OBJECTIVES: The authors assessed the incidence of AKI in patients with acute coronary syndrome (ACS) enrolled in the MATRIX-Access (Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox) trial. METHODS: Among 8,404 patients, 194 (2.3%) were excluded due to missing creatinine values, no or an incomplete coronary angiogram, or previous dialysis. The primary AKI-MATRIX endpoint was AKI, defined as an absolute (>0.5 mg/dl) or a relative (>25%) increase in serum creatinine (sCr). RESULTS: AKI occurred in 634 patients (15.4%) with RA and 712 patients (17.4%) with FA (odds ratio [OR]: 0.87; 95% confidence interval [CI]: 0.77 to 0.98; p = 0.0181). A >25% sCr increase was noted in 633 patients (15.4%) with RA and 710 patients (17.3%) with FA (OR: 0.87; 95% CI: 0.77 to 0.98; p = 0.0195), whereas a >0.5 mg/dl absolute sCr increase occurred in 175 patients (4.3%) with RA versus 223 patients (5.4%) with FA (OR: 0.77; 95% CI: 0.63 to 0.95; p = 0.0131). By implementing the Kidney Disease Improving Global Outcomes criteria, AKI was 3-fold less prevalent and trended lower with RA (OR: 0.85; 95% CI: 0.70 to 1.03; p = 0.090), with stage 3 AKI occurring in 28 patients (0.68%) with RA versus 46 patients (1.12%) with FA (p = 0.0367). Post-intervention dialysis was needed in 6 patients (0.15%) with RA and 14 patients (0.34%) with FA (p = 0.0814). Stratified analyses suggested greater benefit with RA than FA in patients at greater risk for AKI. CONCLUSIONS: In ACS patients who underwent invasive management, RA was associated with a reduced risk of AKI compared with FA. (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX [MATRIX]; NCT01433627).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Andò G, Cortese B, Russo F, et al. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. J Am Coll Cardiol. 2017. PMID: 28528767. doi:10.1016/j.jacc.2017.02.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。